Cargando…
Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma
BACKGROUND: Combined hepatocellular-cholangiocarcinoma (CHC) is a rare and heterogeneous histological subtype of primary liver cancer, which is still poorly understood. This study aimed to describe the epidemiological and clinical features, investigate the prognostic indicators, and develop a compet...
Autores principales: | Chen, Xiaoyuan, Lu, Yiwei, Shi, Xiaoli, Chen, Xuejiao, Rong, Dawei, Han, Guoyong, Zhang, Long, Ni, Chuangye, Zhao, Jie, Gao, Yun, Wang, Xuehao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8683178/ https://www.ncbi.nlm.nih.gov/pubmed/34925507 http://dx.doi.org/10.1155/2021/3002480 |
Ejemplares similares
-
Evaluation of nodal status in intrahepatic cholangiocarcinoma: a population-based study
por: Chen, Xiaoyuan, et al.
Publicado: (2021) -
Promising role of liver transplantation in patients with combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis
por: Chen, Xiaoyuan, et al.
Publicado: (2022) -
Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma
por: Chen, Xiaoyuan, et al.
Publicado: (2022) -
Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma
por: Chen, Xiaoyuan, et al.
Publicado: (2022) -
STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
por: Hao, Xiaopei, et al.
Publicado: (2021)